Sirona Biochem’s Anti-Aging Glycoprotein Successfully Extends Cell Life in Serum Deprivation Study

Vancouver, British Columbia – May 20, 2014 – Sirona Biochem Corp. (TSX-V: SBM.V OTCQX: SRBCF FRANKFURT: ZSB) announces its anti-aging compound TFC-837 was proven to extend cell life with outstanding results in a 12-day serum-deprivation study. The study subjected unprotected and glycoprotein-protected fibroblast cells to a serum-deprived environment for a period of twelve days. By day ten of the study, 100% of the unprotected cells were dead. In contrast, 75% of the glycoprotein-protected cells continued to be fully viable at the conclusion of the twelve day study. “We couldn’t be more excited by these results and the potential value these compounds can create, commented Mr. Neil Belenkie, CEO of Sirona Biochem. Results such as these are the reason we have attracted globally respected partners for this project, including Jean-Michel Cousteau, Fabien Cousteau and the Cincinnati Children’s Hospital Medical Center. This is absolutely groundbreaking technology; the first in a ne
http://bit.ly/1oNVQct